L
Lindsey McCracken
Researcher at University of Pennsylvania
Publications - 8
Citations - 4193
Lindsey McCracken is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Anti-NMDA receptor encephalitis & Encephalitis. The author has an hindex of 8, co-authored 8 publications receiving 3381 citations. Previous affiliations of Lindsey McCracken include Hospital of the University of Pennsylvania & Catalan Institution for Research and Advanced Studies.
Papers
More filters
Journal ArticleDOI
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
Maarten J. Titulaer,Lindsey McCracken,Iñigo Gabilondo,Thaís Armangue,Carol A. Glaser,Takahiro Iizuka,Lawrence S. Honig,Susanne M. Benseler,Izumi Kawachi,Eugenia Martinez-Hernandez,Eugenia Martinez-Hernandez,Esther Aguilar,Nuria Gresa-Arribas,Nicole Ryan-Florance,Abiguei Torrents,Albert Saiz,Myrna R. Rosenfeld,Myrna R. Rosenfeld,Rita J. Balice-Gordon,Francesc Graus,Josep Dalmau,Josep Dalmau,Josep Dalmau +22 more
TL;DR: Most patients with anti-NMDAR encephalitis respond to immunotherapy; second-line immunotherapy is usually effective when first-line treatments fail, and outcomes continued to improve for up to 18 months after symptom onset.
Journal ArticleDOI
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
Nuria Gresa-Arribas,Maarten J. Titulaer,Abiguei Torrents,Esther Aguilar,Lindsey McCracken,Frank Leypoldt,Amy J. Gleichman,Amy J. Gleichman,Rita J. Balice-Gordon,Myrna R. Rosenfeld,David A. Lynch,David A. Lynch,Francesc Graus,Josep Dalmau,Josep Dalmau +14 more
TL;DR: The sensitivity of NMDA receptor antibody testing is higher in CSF than in serum, and antibody titres were higher in patients with poor outcome than in those with good outcome, emphasising the importance of including CSF in antibody studies, and that antibody titre can complement clinical assessments.
Journal ArticleDOI
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
Mar Petit-Pedrol,Thaís Armangue,Thaís Armangue,Xiaoyu Peng,Luis Bataller,Tania Cellucci,Rebecca Davis,Lindsey McCracken,Eugenia Martinez-Hernandez,Warren P. Mason,Michael C. Kruer,David G. Ritacco,Wolfgang Grisold,Brandon F. Meaney,Carmen Alcalá,Peter A.E. Sillevis-Smitt,Maarten J. Titulaer,Rita J. Balice-Gordon,Francesc Graus,Josep Dalmau +19 more
TL;DR: High titres of serum and CSF GABAA receptor antibodies are associated with a severe form of encephalitis with seizures, refractory status epilepticus, or both and are potentially treatable.
Journal ArticleDOI
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
Maarten J. Titulaer,Maarten J. Titulaer,Romana Höftberger,Romana Höftberger,Takahiro Iizuka,Frank Leypoldt,Frank Leypoldt,Lindsey McCracken,Tania Cellucci,Leslie Benson,Leslie Benson,Huidy Shu,Takashi Irioka,Makito Hirano,Gagandeep Singh,Alvaro Cobo Calvo,Kenichi Kaida,Pamela S. Morales,Paul W. Wirtz,Tomotaka Yamamoto,Markus Reindl,Myrna R. Rosenfeld,Francesc Graus,Albert Saiz,Josep Dalmau,Josep Dalmau,Josep Dalmau +26 more
TL;DR: In this paper, the authors report the clinical, radiological, and immunological association of demyelinating disorders with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
Journal ArticleDOI
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.
Ramani Balu,Lindsey McCracken,Eric Lancaster,Francesc Graus,Josep Dalmau,Maarten J. Titulaer +5 more
TL;DR: The NEOS score accurately predicts 1-year functional status in patients with anti-NMDAR encephalitis and could help estimate the clinical course following diagnosis and may aid in identifying patients who could benefit from novel therapies.